Related Experiment Videos
Guidelines from the International Conference on Harmonisation (ICH)
1Medicines and Healthcare Products Regulatory Agency (MHRA), Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK.
Journal of Pharmaceutical and Biomedical Analysis
|August 4, 2005
Summary
This article details international guidelines for registering technical dossiers for medicinal product approval. It highlights the significance of Nuclear Magnetic Resonance (NMR) spectroscopy in drug development and quality control processes.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Regulatory Affairs
Background:
- Technical dossiers are crucial for medicinal product approval.
- International harmonization of regulatory requirements is ongoing.
- Nuclear Magnetic Resonance (NMR) spectroscopy is a key analytical technique in drug development.
Purpose of the Study:
- To describe the development of international guidance for technical dossier registration.
- To discuss the application of NMR spectroscopy within this regulatory framework.
- To provide insights relevant to drug manufacturers and regulatory bodies.
Main Methods:
- Review of international regulatory guidelines.
- Analysis of dossier requirements for medicinal products.
- Focus on the role and validation of NMR spectroscopy data.
Main Results:
- Established international guidance for technical dossier submission.
- Identified specific considerations for NMR spectroscopy data.
- Emphasized the importance of standardized NMR data for regulatory review.
Conclusions:
- International guidance facilitates consistent medicinal product registration.
- NMR spectroscopy plays a vital role in drug characterization and control.
- Adherence to guidance ensures robust technical dossiers for market approval.